AMERICAN BATTERY TECHNOLOGY Co
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Condensed Consolidated Financial Statements (unaudited)
1. Organization and Nature of Operations
American Battery Technology Company (“the Company” or “ABTC”) is a new entrant in the lithium-ion battery industry that is working to increase the domestic U.S. production of battery materials, such as lithium, nickel, cobalt, and manganese through its engagement in the exploration of new primary resources of battery metals, in the development and commercialization of new technologies for the extraction of these battery metals from primary resources, and in the commercialization of an internally developed integrated process for the recycling of lithium-ion batteries. Through this three-pronged approach the Company is working to both increase the domestic production of these battery materials, and to ensure that as these materials reach their end of lives that the constituent elemental battery metals are returned to the domestic manufacturing supply chain in a closed-loop fashion.
The Company was incorporated under the laws of the State of Nevada on October 6, 2011, for the purpose of acquiring rights to mineral properties with the objective of being a producing mineral company. ABTC began operations of its first lithium-ion battery recycling facility in October 2023 and has a limited operating history, and as of March 31, 2024 had not generated or realized revenues from its activities. The principal executive offices are located at 100 Washington Ave., Suite 100, Reno, NV 89503.
Liquidity and Capital Resources
During the nine months ended March 31, 2024, the Company incurred a net loss of $29.1 million and used cash of $12.4 million for operating activities. At March 31, 2024, the Company has a cash balance of $6.0 million and an accumulated deficit of $189.9 million.
The continuation of the Company as a going concern is dependent upon generating profit from its operations and its ability to obtain debt or equity financing. There is no assurance that the Company will be able to generate sufficient profits, obtain such financings, or obtain them on favorable terms, which could limit its operations. Any such financing activities are subject to market conditions. These uncertainties cause substantial doubt to exist as to the Company’s ability to continue as a going concern for 12 months from issuance of these financial statements. These condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. These adjustments could be material.
The going concern assessment excludes the Company’s undrawn amounts from the common stock purchase agreements with Tysadco (Note 12) and the Company’s at-the-market (“ATM”) offering (Note 17), which could provide sources of liquidity.
Based on our current operating plan, unless we generate income from the operations of our facilities and Government Grant Awards, or raise additional capital (debt or equity), it is possible that we will be unable to maintain our financial covenants under our existing Note agreement (Note 10). If such covenant violations are not waived by the Note holder, it would result in an event of default, causing an acceleration of the outstanding balances. If we do raise additional capital through public or private equity offerings, as opposed to debt or additional Note issuances, the ownership interest of our existing stockholders may be diluted.
2. Summary of Significant Accounting Policies
a)Basis of Presentation and Principles of Consolidation
The condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is June 30.
These condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Oroplata Exploraciones E Ingenieria SRL (dissolved), LithiumOre Corporation (formerly Lithortech Resources Inc), ABMC AG, LLC (dissolved) and Aqua Metals Transfer LLC. All inter-company accounts and transactions have been eliminated upon consolidation.
On September 11, 2023, the Company effected a one-for-fifteen reverse-stock-split with respect to the authorized, issued, and outstanding shares of common stock and preferred stock. All share and per-share amounts included in this Form 10-Q are presented as if the stock split had been effective from the beginning of the earliest period presented.
Immaterial Correction of Previously Issued Consolidated Financial Statements
Subsequent to the issuance of the Company’s December 31, 2023 condensed consolidated financial statements, the Company identified errors in the application of Accounting Standards Codification (“ASC”) 710, “Compensation-General,” and ASC 718, “Compensation-Stock Compensation,” related to expense recognition for cash and equity awards that are subject to both service and performance conditions. ASC 710 and ASC 718 require recognition of compensation cost once achievement of the performance condition becomes probable as the requisite service is provided. Historically, the Company did not recognize compensation cost for certain cash and equity awards until the performance conditions in the form of milestones were achieved, and for the Company’s common share warrant performance-based awards, no compensation cost had previously been recognized when the performance conditions either became probable of achievement or were achieved. As the common share warrant and RSU performance-based awards to executive officers and key employees are granted with a fixed dollar value and settled in a variable number of common share warrants or RSUs, these awards are liability-classified and the corresponding compensation cost should be recorded to current or long-term liabilities, depending on expected timing of settlement of the award, once the performance conditions become probable of achievement.
The correction of this error resulted in an increase in compensation cost of $0.9 million as of and for the fiscal year ended June 30, 2023, and an increase in compensation cost of $1.6 million and $0.6 million for the quarters ended September 30, 2023 and December 31, 2023, respectively. For the six-month period ended December 31, 2023, the errors resulted in an increase in compensation cost of $2.2 million. As certain of these awards are liability-classified, the correction of this error resulted in an increase of $0.3 million in accounts payable and accrued liabilities for the current portion of the awards and an increase of $0.8 million in equity compensation liability for the noncurrent portion of the awards as of June 30, 2023.
The Company also identified an error in application of ASC 815, “Derivatives and Hedging,” related to the initial and subsequent recognition of a conversion option in the Company’s convertible notes that does not qualify for equity classification. ASC 815 requires bifurcation of the conversion option with subsequent changes in the fair value of the bifurcated derivative to be recorded in earnings. At issuance of the convertible notes, the Company should have recognized a derivative liability and a corresponding discount on the convertible notes resulting from bifurcation of the derivative, with subsequent changes in the fair value of the derivative liability and accretion of the discount recorded in earnings.
The correction of this error resulted in an increase in interest and other expense of less than $0.1 million for the quarter ended September 30, 2023 and $0.3 million for the quarter ended December 31, 2023. For the six-month period ended December 31, 2023, the error resulted in an increase in interest and other expenses of $0.4 million.
The Company has evaluated the effects of the corrections detailed in the tables below on the previously issued consolidated financial statements, individually and in the aggregate, in accordance with the guidance in ASC 250, “Accounting Changes and Error Corrections.” The Company has concluded such corrections to be immaterial to its previously issued consolidated financial statements. While management believes the effect of the errors is immaterial to the Company’s previously issued consolidated financial statements as of and for the year ended June 30, 2023, and the condensed consolidated financial statements as of and for the three months ended September 30, 2023 and as of and for the three and six months ended December 31, 2023, the financial statement line items impacted by these errors have been corrected. In addition, the immaterial error is being corrected prospectively in the Company’s subsequent quarterly and annual filings.
The tables below reflect the sections of the Company’s condensed consolidated financial statements that were impacted by the error.
** CONSOLIDATED BALANCE SHEET**
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Liabilities and Stockholders’ Equity | |||
| Current liabilities: | |||
| Accounts payable and accrued liabilities | $7,389,864 | $345,000 | $7,734,864 |
| Total current liabilities | 13,389,864 | 345,000 | 13,734,864 |
| Equity compensation liability | - | 833,427 | 833,427 |
| Total liabilities | 13,444,168 | 1,178,427 | 14,622,595 |
| Stockholders’ equity | |||
| Additional paid in capital | $222,626,865 | $(325,494) | $222,301,371 |
| Accumulated deficit | (159,973,575) | (852,933) | (160,826,508) |
| Total stockholders’ equity | 61,214,484 | (1,178,427) | 60,036,057 |
** CONSOLIDATED STATEMENT OF OPERATIONS**
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Operating expenses | |||
| General and administrative | $11,960,831 | $887,300 | $12,848,131 |
| Research and development | 7,703,895 | (138,160) | 7,565,735 |
| Exploration | 1,910,548 | 103,793 | 2,014,341 |
| Total operating expenses | 21,575,274 | 852,933 | 22,428,207 |
| Net loss before other income (expense) | $(21,575,274) | $(852,933) | $(22,428,207) |
| Net loss attributable to common stockholders | $(21,338,207) | $(852,933) | $(22,191,140) |
| Net loss per share, basic and diluted | $(0.49) | $(0.02) | $(0.51) |
** CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY**
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Stockholders’ Equity | |||
| Additional Paid-In Capital: | |||
| Stock-based compensation expense | $9,249,462 | $(325,494) | $8,923,968 |
| Balance, June 30, 2023 | $222,626,865 | $(325,494) | $222,301,371 |
| Accumulated Deficit | |||
| Net loss for period | $(21,338,207) | $(852,933) | $(22,191,140) |
| Balance, June 30, 2023 | (159,973,575) | $(852,933) | $(160,826,508) |
** CONSOLIDATED STATEMENTS OF CASH FLOWS**
| As Reported · Adjustments · As Corrected | ||||
|---|---|---|---|---|
| Operating Activities | ||||
| Net loss attributable to stockholders | $(21,338,207) | $(852,933) | $(22,191,140) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock-based compensation | 9,249,462 | 507,933 | 9,757,395 | |
| Changes in operating assets and liabilities: | ||||
| Accounts payable and accrued liabilities | $(187,796) | $345,000 | $157,204 | |
| Net Cash Used in Operating Activities | $(13,367,980) | $ | - | $(13,367,980) |
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Operating expenses | |||
| General and administrative | $2,948,846 | $105,152 | $3,053,998 |
| Research and development | 2,155,314 | 1,458,538 | 3,613,852 |
| Exploration | 1,279,782 | 70,138 | 1,349,920 |
| Total operating expenses | 6,383,942 | 1,633,827 | 8,017,769 |
| Net loss before other income (expense) | $(6,383,942) | $(1,633,827) | $(8,017,769) |
| Other income (expense) | |||
| Amortization of financing costs | $(706,731) | $(26,165) | $(732,896) |
| Total other income (expense) | (848,043) | (26,165) | (874,208) |
| Net loss attributable to common stockholders | $(7,231,985) | $(1,659,992) | $(8,891,977) |
| Net loss per share, basic and diluted | $(0.16) | $(0.03) | $(0.19) |
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Stockholders’ Equity | |||
| Additional Paid-In Capital: | |||
| Balance, June 30, 2023 | $222,626,865 | $(325,494) | $222,301,371 |
| Stock-based compensation expense | 1,921,442 | 981,396 | 2,902,838 |
| Balance, September 30, 2023 | $226,317,285 | $655,903 | $226,973,188 |
| Accumulated Deficit | |||
| Balance, June 30, 2023 | $(159,973,575) | $(852,933) | $(160,826,508) |
| Net loss for period | (7,231,985) | (1,659,992) | (8,891,977) |
| Balance, September 30, 2023 | $(167,205,560) | $(2,512,926) | $(169,718,486) |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| As Reported · Adjustments · As Corrected | ||||
|---|---|---|---|---|
| Operating Activities | ||||
| Net loss attributable to stockholders | $(7,231,985) | $(1,659,992) | $(8,891,977) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Accretion expense | $256,459 | $26,165 | $282,624 | |
| Stock-based compensation | 1,921,442 | 1,447,827 | 3,369,269 | |
| Changes in operating assets and liabilities: | ||||
| Accounts payable and accrued liabilities | $228,071 | $186,000 | $414,071 | |
| Net Cash Used in Operating Activities | $(4,758,984) | $ | - | $(4,758,984) |
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Operating expenses | |||
| General and administrative | $4,310,452 | $106,264 | $4,416,716 |
| Research and development | 3,148,873 | 420,294 | 3,569,167 |
| Exploration costs | 771,523 | 51,902 | 823,425 |
| Total operating expenses | 8,230,848 | 578,459 | 8,809,307 |
| Net loss before other income (expense) | $(8,230,848) | $(578,459) | $(8,809,307) |
| Other income (expense) | |||
| Amortization and accretion of financing costs | $(1,053,766) | $(78,492) | $(1,132,258) |
| Change in fair value of derivative liability | - | (229,473) | (229,473) |
| Total other income (expense) | (1,060,587) | (307,965) | (1,368,552) |
| Net loss | $(9,291,435) | $(886,424) | $(10,177,859) |
| Net loss per share, basic and diluted | $(0.19) | $(0.02) | $(0.21) |
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Operating expenses | |||
| General and administrative | $7,259,298 | $211,415 | $7,470,713 |
| Research and development | 5,304,187 | 1,878,831 | 7,183,018 |
| Exploration costs | 2,051,305 | 122,040 | 2,173,345 |
| Total operating expenses | 14,614,790 | 2,212,286 | 16,827,076 |
| Net loss before other income (expense) | $(14,614,790) | $(2,212,286) | $(16,827,076) |
| Other income (expense) | |||
| Amortization and accretion of financing costs | $(1,760,497) | $(104,657) | $(1,865,154) |
| Change in fair value of derivative liability | - | (229,473) | (229,473) |
| Total other income (expense) | (1,908,630) | (334,130) | (2,242,760) |
| Net loss | $(16,523,420) | $(2,546,416) | $(19,069,836) |
| Net loss per share, basic and diluted | $(0.35) | $(0.05) | $(0.40) |
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Stockholders’ Equity | |||
| Additional Paid-In Capital: | |||
| Balance, September 30, 2023 | $226,317,285 | $655,903 | $226,973,188 |
| Stock-based compensation expense | 3,836,466 | 146,877 | 3,983,343 |
| Balance, December 31, 2023 | $243,020,935 | $802,779 | $243,823,714 |
| Accumulated Deficit | |||
| Balance, September 30, 2023 | $(167,205,560) | $(2,512,926) | $(169,718,486 |
| Net loss for period | (9,291,435) | (886,424) | (10,177,859) |
| Balance, December 31, 2023 | $(176,496,995) | $(3,399,350) | $(179,896,345) |
| As Reported | Adjustments | As Corrected | |
|---|---|---|---|
| Stockholders’ Equity | |||
| Additional Paid-In Capital: | |||
| Balance, June 30, 2023 | $222,626,865 | $(325,494) | $222,301,371 |
| Stock-based compensation expense | 5,757,908 | 1,128,273 | 6,886,181 |
| Balance, December 31, 2023 | $243,020,935 | $802,779 | $243,823,714 |
| Accumulated Deficit | |||
| Balance, June 30, 2023 | $(159,973,575) | $(852,933) | $(160,826,508) |
| Net loss for period | (16,523,420) | (2,546,416) | (19,069,836) |
| Balance, December 31, 2023 | $(176,496,995) | $(3,399,350) | $(179,896,345) |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| As Reported · Adjustments · As Corrected | ||||
|---|---|---|---|---|
| Operating Activities | ||||
| Net loss attributable to stockholders | $(16,523,420) | $(2,546,416) | $(19,069,836) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Accretion of financing costs | $1,760,497 | $104,657 | $1,865,154 | |
| Stock-based compensation | 5,757,908 | 1,933,603 | 7,691,511 | |
| Shares issued for professional services | (132) | (316) | (448) | |
| Change in fair value of derivative liability | - | 229,473 | 229,473 | |
| Changes in operating assets and liabilities: | ||||
| Accounts payable and accrued liabilities | $2,223,865 | $279,000 | $2,502,865 | |
| Net Cash Used in Operating Activities | $(7,418,700) | $ | - | $(7,418,700) |
b)Use of Estimates
The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, valuation and recoverability of long-lived assets and intangible assets subject to impairment testing, and deferred income tax asset valuation allowances.
The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations may be affected.
c)Long-Lived Assets
Long-lived assets, such as property and equipment, mineral properties, and purchased intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 360, “Property, Plant, and Equipment.” Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. The Company’s long-lived assets consist of buildings, vehicles, equipment, and land. Buildings, vehicles, and equipment are depreciated on a straight-line basis over their estimated value lives ranging between three and thirty years.
The recoverability of assets is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by an asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount exceeds the estimated fair value of the asset. Any impairment in value is recognized as an expense in the period when the impairment occurs. No impairment charges were recorded in the three or nine months ended March 31, 2024.
Expenses for major repairs and maintenance which extend the useful lives of property and equipment are capitalized. All other maintenance expenses, including planned major maintenance activities, are expensed as incurred. Gains or losses from property disposals are included in income or loss from operations.
d)Mining Properties
Costs of lease, exploration, carrying and retaining unproven mineral properties are expensed as incurred. The Company expenses all mineral exploration costs as incurred as it is still in the exploration stage. If the Company identifies proven and probable reserves in its investigation of its properties and upon development of a plan for operating a mine, it will enter the development stage and capitalize future costs until production is established. When a property reaches the production stage, the related capitalized costs are amortized on a units-of-production basis over the proven and probable reserves following the commencement of production. Interest expense allocable to the cost of developing mining properties and to construct new facilities is capitalized until assets are ready for their intended use.
To date, the Company has not established the commercial feasibility of any exploration prospects; therefore, all exploration costs are being expensed.
ASC 930-805, “Extractive Activities-Mining: Business Combinations,” states that mineral rights consist of the legal right to explore, extract, and retain at least a portion of the benefits from mineral deposits. Mining assets include mineral rights which are considered tangible assets under ASC 930-805. ASC 930-805 requires that mineral rights be recognized at fair value as of the acquisition date. As a result, the direct costs to acquire mineral rights are initially capitalized as tangible assets. Mineral rights include costs associated with acquiring patented and unpatented mining claims.
e)Intangible Assets
Intangible assets consist of water rights that have indefinite useful lives are tested annually for impairment, or more frequently if events and circumstances indicate that the asset might be impaired. An impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair value. Annually, or when there is a triggering event, the Company first performs a qualitative assessment by evaluating all relevant events and circumstances to determine if it is more likely than not that the indefinite-lived intangible assets are impaired; this includes considering any potential effect on significant inputs to determining the fair value of the indefinite-lived intangible assets. When it is more likely than not that an indefinite-lived intangible asset is impaired, then the Company calculates the fair value of the intangible asset and performs a quantitative impairment test. No impairment charges were recorded in the three or nine months ended March 31, 2024.
f)Loss per Share
The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share.” ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) attributable to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and awards. At March 31, 2024, the Company had 10,581,138 potentially dilutive shares outstanding, consisting of 1,355,853 from convertible notes,5,757,894 from warrants and 3,467,391 from share awards outstanding. As the Company has reported losses for all periods presented, all potentially dilutive securities are anti-dilutive, and accordingly, basic net loss per share equaled diluted net loss per share.
g)Stock-based Compensation
The Company records stock-based compensation in accordance with ASC 718, “Stock Compensation,” using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. The Company utilizes the Black Scholes method when calculating stock-based compensation expense relating to stock option awards and warrants.
The Company records the stock-based compensation expense attributed to share awards in accordance with US GAAP using the graded-vesting method. The Company amortizes the grant date fair value over the respective vesting period, beginning with recognition on the date of grant. Compensation in the form of warrants is limited to executives, and recorded as a liability until the warrant is exercised or expires. Executives may also receive compensation in the form of RSUs that are recorded as a liability until the award is settled in shares of common stock. The liability classification of these awards is based on the total value of the award granted at a fixed value but settled in a variable number of warrants or RSUs until the milestones are achieved and the warrants or RSUs are issued.
h)Exploration Costs
Mineral property acquisition costs are capitalized as incurred. Exploration and evaluation costs are expensed as incurred until proven and probable reserves are established. The Company assesses the carrying costs for impairment under ASC 360, “Property, Plant, and Equipment,” at each period end. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs then incurred to develop such property are capitalized on a prospective basis. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserve. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to operations. As of March 31, 2024 and 2023, the Company has not capitalized any such mineral property costs.
i)Research and Development Costs
Research and development (“R&D”) costs are accounted for in accordance with ASC 730, “Research and Development.” ASC 730-10-25 requires that all R&D costs be recognized as an expense as incurred. However, some costs associated with R&D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.
The Company has been awarded federal grant awards for specific R&D programs. Under Accounting Standards Update (“ASU”) No. 2021-10 “Government Assistance,” the Company recognizes invoiced government funds as an offset to R&D costs in the period the qualifying costs are incurred. As the federal grants receivable are not deemed to have any significant realization risk, the Company believes this best reflects the expected net expenditures associated with these programs.
j)Leases
The Company follows the guidance of ASC 842, “Leases,” which requires an entity to recognize a right-of-use (“ROU”) asset and a lease liability for virtually all leases. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines the present value of lease payments utilizing its incremental borrowing rate, as the implicit rate of interest in the respective leases is not readily determinable. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be.
The Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less. The Company recognizes the lease payments associated with its short-term office space leases as an expense on a straight-line basis over the lease term. Variable lease payments associated with these leases are recognized and presented in the same manner as for all other Company leases.
k)Income Taxes
The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards.
Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
Any uncertain tax position liabilities have been applied against the deferred tax balance given that there is a sufficient net operating loss to cover any penalties and fees associated with the uncertain tax position. The Company assesses each of its identified uncertain positions and determines whether any potential penalties and interest liability should be accrued at the balance sheet dates.
Due to the Company’s cumulative loss position since inception, the likelihood of deferred tax assets being realized does not meet the more likely than not assessment guidelines. Accordingly, a valuation allowance equal to the deferred tax asset has been recorded at March 31, 2024 and June 30, 2023.
l)Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The amendment in this update expands segment disclosures by requiring disclosures about significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This update is effective for our annual report for fiscal year 2025, for interim period reporting beginning in fiscal year 2026, with early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. We are currently evaluating the timing of adoption and the impact of this ASU on our Consolidated Financial Statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvement to Income Tax Disclosures.” The amendments further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This ASU is effective for our annual report for fiscal year 2026, with early adoption permitted, and should be applied either prospectively or retrospectively. We are currently evaluating the timing of adoption and impact of this ASU on our Consolidated Financial Statements and related disclosures.
m)Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in earnings in the condensed consolidated statements of operations.
n)Convertible Notes
The Company evaluates all conversion, repurchase and redemption features contained in a debt instrument to determine if there are any embedded features that require bifurcation as a derivative. The Company accounts for its convertible notes as a long-term liability, with the current portion reclassified to a short-term liability, equal to the proceeds received from issuance, including any embedded conversion features, net of the unamortized debt discount and offering costs in the accompanying unaudited condensed consolidated balance sheets. The debt discount, debt issuance and offering costs are amortized over the term of the convertible notes, using the effective interest method, as interest expense in the accompanying unaudited condensed consolidated statements of operations.
o)Inventory
Inventory is stated at the lower of cost or market (net realizable value). The Company performs an assessment of the recoverability of capitalized inventory during each reporting period and writes down any excess and obsolete inventories to their net realizable value in the period in which the impairment is first identified.
p)Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2024 and June 30, 2023.
q)Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed consolidated balance sheets.
r)Other Current Assets
Other Current Assets are comprised of payroll tax credits related to research and development activities per IRS form 6765.
s)Accrued Claims and Contingencies
The Company is subject to various claims and contingencies related to lawsuits. A liability is recorded for claims, legal costs or other contingencies when the risk of loss is probable and reasonable estimable. The required reserves may change due to new developments in each period.
3. Inventories
The Company’s inventory for its lithium-ion battery recycling operation is comprised of raw materials, in the form of battery feedstock, and finished goods, in the form of black mass and other metals. Inventory is valued at the lower of average cost or net realizable value. The carrying value of inventory includes those costs to acquire battery feedstock and any related carrying and processing costs incurred by the Company.
| March 31, 2024 | June 30, 2023 | |
|---|---|---|
| Raw materials | $436,968 | $125,204 |
| Finished goods | 185,577 | - |
| Total | $622,545 | $125,204 |
4. Government Grant and Tax Credit Awards
Grants receivable represent qualifying costs incurred where there is reasonable assurance that the conditions of the grant have been met but the corresponding funds have not been received as of the reporting date. As collections from the federal government have been and are expected to continue to be timely, no allowance for doubtful accounts has been established. If amounts become uncollectible, they will be charged to operations. Grants receivable was $527,723 and $320,457 as of March 31, 2024 and June 30, 2023, respectively. The Company recognizes invoiced government funds as an offset to R&D costs in the period the qualifying costs are incurred.
On January 20, 2021, the U.S. Department of Energy (“DOE”) announced that the Company had been selected for award negotiation for a three-year project with a total budget of $4.5 million for the field demonstration of its selective leaching, targeted purification, and electro-chemical production of battery grade lithium hydroxide from domestic claystone resources technology. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, or up to $2.3 million. The prime agreement contract for this grant (the “AMMTO grant”) was issued with a project start date of October 1, 2021. The Company began receiving funds related to this award during the fiscal year ending June 30, 2022. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $1,560,962, which represents 68% of the total eligible reimbursements.
On August 16, 2021, the Company received a contract award for a 30-month project with a total budget of $2.0 million from the United States Advanced Battery Consortium (the “USABC grant”) as part of a competitively bid project, through which the Company will receive reimbursement for up to $500,000 of eligible expenditures. The objective of the contract award is for the commercial-scale development and demonstration of an integrated lithium-ion battery recycling system, the production of battery cathode grade metal products, the synthesis of high energy density active cathode material from these recycled battery metals, and the fabrication of large format automotive battery cells from these recycled materials and the testing of these cells against otherwise identical cells made from virgin sourced metals. The Company began receiving funds related to this award during the fiscal year ending June 30, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $479,939, which represents 96% of the total eligible reimbursements.
(unaudited
On October 21, 2022, the U.S. DOE announced that the Company had been selected for award negotiation for a five-year project with a total budget of $115.5 million to design, construct, and commission a first-of-kind lithium hydroxide refinery using Nevada-based claystone as the feedstock to expand domestic manufacturing of battery grade lithium hydroxide for lithium-ion batteries for electric vehicles, with a focus on domestic processing of materials and components that are currently imported from foreign countries. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, up to $57.7 million. The prime agreement contract for this grant was issued with a project start date of September 1, 2023. The Company began receiving funds related to this award during the period ending December 31, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $1,457,877, which represents 3% of the total eligible reimbursements.
On November 17, 2022, the U.S. DOE announced that the Company had been selected for award negotiation for a three-year project with a total budget of $20.0 million to demonstrate and commercialize next generation techniques for its lithium-ion battery recycling processes to produce low-cost and low-environmental impact domestic battery materials. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, up to $10.0 million. The prime agreement contract for this grant was issued with a project start date of October 1, 2023. The Company began receiving funds related to this award during the period ending December 31, 2023. As of March 31, 2024, the cumulative funds invoiced for this grant totaled $421,735, which represents 4% of the total eligible reimbursements.
On March 28, 2024, ABTC was selected for a tax credit for up to $19.5 million through the Qualifying Advanced Energy Project Credits program (48C). This tax credit was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the U.S.DOE, which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. This tax credit may be utilized both for the reimbursement of capital expenditures spent to date at ABTC’s battery recycling facility in the Tahoe-Reno Industrial Center (TRIC) in Storey County, Nevada.
Also on March 28, 2024, ABTC was selected for an additional tax credit of up to $40.5 million through the 48C program, which may be used in support of the design and construction of a new commercial battery recycling facility to be located in the United States.
5. Other Deposits
On March 1, 2023, the Company and Linico Corporation (“Linico”) entered into an Asset Purchase Agreement (“APA”) whereby the Company acquired specific tangible equipment and personal property for an aggregate purchase price of $6.0 million. Contemporaneously with the signing of the APA, the Company and Linico entered into another agreement, the Membership Interest Purchase Agreement (“MIPA”), whereby the Company would acquire 100% of the membership interests in Aqua Metals Transfer, LLC, principally real property consisting of land and a building in the Tahoe-Reno Industrial Center (TRIC) at 2500 Peru Drive, McCarran, Nevada, for an aggregate purchase price of $21.6 million. The purchase was finalized on August 11, 2023 at which time the aggregate total of $27.6 million worth of deposits was bifurcated into both real and personal property assets, inclusive of both agreements (See Note 6).
On June 30, 2023, the Company and Linico entered into an amendment to the MIPA. Pursuant to the terms of the amended agreement, the parties agreed to (i) remove the requirement that $1.5 million of the purchase price be held in escrow for the settlement of indemnification claims, (ii) transfer back to the Company 128,206 common shares, previously issued by the Company, in exchange for the elimination of such indemnification escrow, (iii) add a purchase price adjustment to the extent that, as of four months after the registration statement on Form S-3 filed by the Company is declared effective by the SEC, the value of the portion of the purchase price comprised of shares does not equal at least $6.0 million, (iv) provide for an interim water rights agreement through the final purchase price payment date, (iv) advance the closing date to as soon as practicable after the declaration of effectiveness of the resale registration statement on Form S-3, and (v) remove the deadline to close the acquisition by June 30, 2023.
6. Property, Plant and Equipment
The table below presents the property, plant and equipment as of March 31, 2024 and June 30, 2023:
| Land · Building · Equipment · Total | ||||||
|---|---|---|---|---|---|---|
| Cost: | ||||||
| Balance, June 30, 2023 | $6,728,838 | $17,508,486 | $5,870,496 | $30,107,820 | ||
| Additions | 4,126,833 | 22,406,792 | 9,213,570 | 35,747,196 | ||
| Balance, March 31, 2024 | $10,855,671 | $39,915,278 | $15,084,066 | $65,855,016 | ||
| Accumulated Depreciation: | ||||||
| Balance, June 30, 2023 | $ | - | $ | - | $161,721 | $161,721 |
| Additions | 106,644 | 106,644 | ||||
| Balance, March 31, 2024 | $ | - | $ | - | $268,365 | $268,365 |
| Carrying Amounts: | ||||||
| Balance, June 30, 2023 | $6,728,838 | $17,508,486 | $5,708,775 | $29,946,099 | ||
| Balance, March 31, 2024 | $10,855,671 | $39,915,278 | $14,815,702 | $65,586,651 | ||
On August 11, 2023, the Company finalized the purchase of its commercial-scale battery recycling facility located in the TRIC, as indicated in Note 5. At that time, the aggregate total of $27.6 million in deposits was reclassified to Property, Plant and Equipment. The Company has installed additional equipment on site to accelerate the first commercial scale implementation of its internally developed lithium-ion battery recycling technologies.
7. Mining Properties
On July 21, 2022, the Company exercised the option to purchase the rights to unpatented lode claims in Tonopah, Nevada. Since that time, the Company has worked with third parties to conduct drill programs and analysis to verify the grade and continuity of the mining claims. Over 50% of the inferred mineral resources have been upgraded to measured and indicated classifications. The Company is still in the exploration stage and expenses all mineral exploration costs. If the Company identifies proven and probable reserves and develops an economic plan for operating a mine, it will enter the development stage and capitalize future costs until production is established.
8. Intangible Assets
On September 12, 2023, the Company acquired approximately 40.52-acre feet of water rights from the Thomas C. Woodward Living Trust, valued at $0.1 million. The water rights are treated in accordance with ASC 350, “Intangible Assets,” and have an unlimited useful life subject to beneficial use.
The Company’s acquisition of the commercial-scale battery recycling facility at the TRIC included water rights valued at $0.6 million and are described as an eighteen and forty-five one-hundredths (18.45) acre-foot/annually portion of the Truckee-Carson Irrigation District, Serial Number 1081-A-1. These are appurtenant to a certain real property located in Storey County, Nevada, described as Storey County Assessor Parcel Number 021-37-104 and have an unlimited useful life upon assignment to a property through use of a will-serve, which has no expiration date.
The table below presents total intangible assets at:
| March 31, 2024 | June 30, 2023 | |
|---|---|---|
| Water rights | $4,584,831 | $3,851,899 |
9. Accounts Payable and Accrued Liabilities
The table below presents total accounts payable and accrued liabilities at:
| March 31, 2024 | June 30, 2023 | |
|---|---|---|
| Trade payables | $2,949,290 | $1,831,686 |
| Accrued fixed assets | 1,999,331 | 4,404,034 |
| Accrued expenses | 1,226,040 | 1,377,660 |
| Right-of-use liability, current | 86,030 | 121,484 |
| Total accounts payable and accrued liabilities | $6,260,691 | $7,734,864 |
10. Notes Payable
On May 17, 2023, the Company entered into a Credit Agreement (the “Credit Agreement”) with Mercuria Investments US, Inc. for pre-payment on the purchase of the Company’s recycled battery metal products. As such, inventory serves as collateral for outstanding balances. The Credit Agreement provides for an aggregate loan amount of up to $20 million, comprised of (i) an initial term loan in the aggregate principal amount of $6 million and (ii) delayed draw term loan commitments in an aggregate amount equal to $14 million. Borrowings under the Credit Agreement carry interest calculated as the secured overnight financing rate published on the Federal Reserve Bank of New York’s website, plus the applicable credit spread adjustment, based on the elected interest period, plus an applicable margin rate of 6%. The agreement contains provisions that allow the Company to remit principal and interest payments via future delivery of its initial recycling byproduct, black mass.
On August 30, 2023, the Company caused the repayment in full of all indebtedness, liabilities and other obligations under, and terminated, its former credit agreement, dated as of May 17, 2023 by and among the Company, as Borrower, and Mercuria Investments US, Inc., as Agent. The Company did not incur any material early termination penalties because of such termination of the credit agreement. The Company remains engaged with Mercuria Investments US, Inc. in a marketing and presale capacity.
On August 29, 2023, the Company and High Trail (the “Buyers”) entered into a Securities Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company sold to the Buyers up to $51.0 million of a new series of senior secured convertible notes (the “Notes”). To date, $25.0 million has been received and $12.6 million has been repaid. The remaining $26 million under the facility includes $13.5 million with the condition that the Company started trading on the Nasdaq Capital Market, had $250,000 in sales, and establish an ATM or ELOC, and another $12.5 million at the discretion of the Buyers. Buyers may request partial redemptions of up to an aggregate of $1.8 million on the 15 th of each month or may convert the Notes into shares of common stock of the Company (“Conversion Shares”) at a conversion rate of 110% of the last reported sales price on the date of the agreement to acquire such Notes. The Notes bear zero coupon, mature on September 1, 2025, require a minimum of $5.0 million maintained in cash and cash equivalents, and are secured by certain real property and cash and investment accounts of the Company.
The Company analyzed the conversion features of the Notes for derivative accounting considerations under ASC 815-15, “Derivatives and Hedging,” and determined a conversion option should be bifurcated and separately accounted for as a derivative liability. Accordingly, the derivative liability is carried at fair value at each reporting date with the corresponding gain or loss reflected in earnings in the condensed consolidated statements of operations. SeeCorrection of Previously Issued Consolidated Financial Statements in Note 2. The Company determined the derivative liability to have a fair value of $0.4 million at issuance of the Notes. For the three and nine months ended March 31, 2024, the Company recorded a loss on the change in fair value of the derivative liability of $0.2 million and $0.4 million, respectively. As of March 31, 2024, the fair value of the derivative liability was $0.8 million. The fair value of the derivative liability is classified within Level 3 of the fair value hierarchy and was determined using the Black-Scholes option pricing model with assumptions as of March 31, 2024 including a volatility of 81.1% and a risk-free-rate of 4.79%.
Note discount and issuance costs totaled $4.7 million and reduced the carrying value of the Notes as a debt discount. The carrying value, net of debt discount and issuance costs, is being accreted over the term of the Notes from date of issuance to date of full repayment, expected to be in October 2024 based on partial redemption payments, using the effective interest rate method. For the nine months ended March 31, 2024, amortization of debt discount and issuance costs totaled $2.8 million.
The table below presents the net carrying amounts of the Notes as of:
| March 31, 2024 · June 30, 2023 | |||
|---|---|---|---|
| Principal outstanding | $12,483,333 | $ | - |
| Unamortized debt discount and issuance costs | (2,520,864) | - | |
| Derivative liability associated with convertible notes | 366,298 | - | |
| Changes in fair market value of derivative liability | 419,739 | - | |
| Net carrying value | $10,748,506 | $ | - |
The table below presents the maturities of notes payable as of March 31, 2024:
| March 31, 2025 | $12,483,333 | |
|---|---|---|
| March 31, 2026 | - | |
| Total note payments | 12,483,333 | |
| Less: unamortized debt discount and issuance costs | (2,520,864) | |
| Derivative liability, at fair value, less amortization | 786,037 | |
| Total notes payable | $10,748,506 | |
| Notes payable, current | $10,748,506 | |
| Notes payable, non-current | $ | - |
11. Leases
A lease provides the lessee the right to control the use of an identified asset for a period in exchange for consideration. Operating lease right-of-use assets (“RoU assets”) are presented within the asset section of the Company’s consolidated balance sheets, while lease liabilities are included within the liability section of the Company’s consolidated balance sheets at March 31, 2024 and June 30, 2023.
RoU assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. RoU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Most operating leases contain renewal options that provide for rent increases based on prevailing market conditions. The terms used to calculate the RoU assets for certain properties include the renewal options that the Company is reasonably certain to exercise.
The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not readily determinable, the Company estimates a rate of 8.0% for the nine months ending March 31, 2024 and 2023, based primarily on historical lending agreements. RoU assets include lease payments required to be made prior to commencement and exclude lease incentives. Both RoU assets and the related lease liability exclude variable payments not based on an index or rate, which are treated as period costs. The Company’s lease agreements do not contain significant residual value guarantees, restrictions, or covenants.
The Company occupies office facilities under lease agreements that expire at various dates, many of which do not exceed a year in length. Total operating lease costs for the nine months ended March 31, 2024 and 2023, were each approximately $0.1 million. The Company does not have any finance leases as of March 31, 2024 and 2023.
As of March 31, 2024, current lease liabilities of $0.1 million are included in “Accounts payable and accrued liabilities” on the consolidated balance sheets. The table below presents total operating lease RoU assets and lease liabilities at March 31, 2024 and June 30, 2023:
| March 31, 2024 | June 30, 2023 | |
|---|---|---|
| Operating lease right-of-use asset | $67,366 | $143,154 |
| Operating lease liabilities | $86,030 | $175,788 |
The table below presents the maturities of operating lease liabilities as of March 31, 2024:
| March 31, 2025 | $88,632 | |
|---|---|---|
| March 31, 2026 | - | |
| Total lease payments | 88,632 | |
| Less: discount | (2,601) | |
| Total operating lease liabilities | $86,030 | |
| Operating lease liabilities, current | $86,030 | |
| Operating lease liabilities, non-current | $ | - |
The table below presents the weighted average remaining lease term for operating leases and weighted average discount rate used in calculating operating lease right-of-use asset as of March 31, 2024.
| Weighted average lease term (years) | 0.67 |
|---|---|
| Weighted average discount rate | 8.00% |
12. Stockholders’ Equity
On September 21, 2023, the Company’s common stock began trading on the Nasdaq Capital Market under the symbol “ABAT.” The Company was previously traded on the OTCQX Markets under the symbol “ABML.”
Preferred Stock
Our amended and restated articles of incorporation authorize shares of preferred stock and provide that shares of preferred stock may be issued from time to time in one or more series. Our board of directors will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Our board of directors will be able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of our board of directors to issue shares of preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal of existing management.
To date, the Company has authorized a total of 1,666,667 shares of preferred stock. Of this amount the Company has designated a total of 233,334 shares to three classes of preferred stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock. As of June 30, 2023 and March 31, 2024, no shares of any of these classes are issued and outstanding. A description of each class of preferred stock is listed below.
Series A Preferred Stock
The Company has 33,334 shares of Series A Preferred Stock authorized with a par value of $0.001 per share. The Company hadnil shares of Series A Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.
Series B Preferred Stock
The Company has 133,334 shares of Series B Preferred Stock authorized with a par value of $10.00 per share. The Company hadnil shares of Series B Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.
Series C Preferred Stock
The Company has 66,667 shares of Series C Preferred Stock authorized with a par value of $10.00 per share. The Company hadnil shares of Series C Preferred Stock issued and outstanding on March 31, 2024, and June 30, 2023.
Common Stock
The Company has 80.0 million shares of common stock authorized, with a par value of $0.001 per share.
On September 11, 2023, in preparation for listing on the Nasdaq Capital Market, the Company implemented a one-for-fifteen (1-for-15) reverse split of our common stock. Prior to the reverse stock split the Company had 692,068,218 shares of common stock issued and outstanding, and after the reverse stock split, the Company had approximately 46,137,882 shares of common stock issued and outstanding. Immediately after the reverse stock split, each stockholder’s percentage ownership interest in the Company and proportional voting power remained unchanged aside from rounding fractional shares into whole shares, resulting in an additional 59,164 common shares issued. The reverse stock split did not change the par value of the common stock or preferred stock.
12. Stockholders’ Equity (continued)
Common Stock (continued)
Nine months ended March 31, 2024:
During the period the Company issued 1,326 common shares that were previously listed as issuable as of June 30, 2023. These shares for professional services relate to previously earned board compensation.
During the period, the Company issued 909,972 common shares with an issuance date fair value of $4.6 million to executives, directors and employees pursuant to share award service and performance achievements. This included 171,500 RSUs granted upon election by officers of the Company to receive warrants and RSUs in lieu of cash bonuses.
On July 28, 2023, the Company recorded an increase of $0.2 million to stockholders’ equity for the change in fair value between the balance sheet date of June 30, 2023 and the fair value on the date the shares were returned. These shares were pursuant to the Company modifying its building purchase agreement to nullify a $1.5 million indemnification requirement and reclaim 128,205 shares that it had previously issued to the Selling Stockholder (See Note 5).
During the period, the Company filed prospectus supplements related to the offer and sale from time to time of up to 8,666,667 common shares directly by the Company at market prices, to Tysadco Partners, LLC, a Delaware limited liability company, pursuant to the terms of written sales agreement(s) (“Tysadco Agreement”). Pursuant to the Tysadco Agreement, the Company may offer and sell up to 8,666,667 common shares of the Company at a purchase price of 95% of the weighted-average price, with a minimum request of 33,333 shares. During the period, the Company sold 8,209,262 common shares for total proceeds of $27.8 million, of which $2.4 million is recorded as a subscription receivable on the condensed consolidated balance sheet at March 31, 2024.
During the period, the Company issued 45,545 common shares pursuant to cashless exercise of 50,000 share purchase warrants exercised as of June 30, 2023. During the period, the Company received cash proceeds of $37,500 pursuant to 33,334 share purchase warrants. Also during the period, the Company issued 39,883 common shares pursuant to cashless exercise of 66,667 share purchase warrants.
During the period, the Company recognized stock-based compensation expense of approximately $12.3 million, which was an increase to additional paid-in capital, a component of stockholders’ equity. Of the amount, approximately $4.4 million was recognized for officers and directors of the Company. SeeCorrection of Previously Issued Consolidated Financial Statements in Note 2.
Nine months ended March 31, 2023:
During the period, the Company issued 293,908 common shares pursuant the vesting of restricted share units issued to employees and directors of the Company. Of the vested shares,166,574 common shares with a fair value of approximately $1.7 million were issued to officers of the Company.
During the period, the Company sold 8,209,262 common shares pursuant the Share Purchase Agreement, effective April 2, 2021. The proceeds totaled $3.6 million, all of which were received prior to March 31, 2023.
During the period the Company issued 10,009 common shares for professional services, with a fair value of approximately $104,000.
During the period, the Company recognized stock-based compensation expense of approximately $6.1 million, which was an increase to additional paid-in capital, a component of stockholders’ equity. Of the amount, approximately $2.7 million was recognized for officers and directors of the Company.
13. Share Purchase Warrants
During the nine months ended March 31, 2024, there were 73,217 common shares issued related to warrants exercised, of which 39,883 were issued pursuant to a cashless exercise of 66,667 share purchase warrants. In addition, there were 249,119 warrants vested related to previously granted stock-based compensation to officers of the Company, and 171,500 warrants granted upon election by officers of the Company to receive warrants and RSUs in lieu of cash bonuses.
| Number of Warrants | Weighted Average Exercise Price | |
|---|---|---|
| Balance, June 30, 2023 | 5,729,360 | $14.53 |
| Granted | 236,271 | 3.59 |
| Exercised | (100,002) | (1.13) |
| Expired | (107,735) | (3.75) |
| Balance, March 31, 2024 | 5,757,894 | $14.55 |
Additional information regarding share purchase warrants as of March 31, 2024, is as follows:
| Outstanding and Exercisable | ||
|---|---|---|
| Range of Exercise Prices | Number of Warrants | Weighted Average Remaining Contractual Life (years) |
| $1.13 - $4.33 | 919,214 | 0.33 |
| $6.53 - $13.13 | 3,015,705 | 1.24 |
| $23.10 - $26.25 | 1,822,975 | 0.74 |
| 5,757,894 | 2.31 | |
14. Equity Compensation Awards
The Company has established the 2021 Retention Plan (“the Retention Plan”) to issue shares in the effort to retain key executives, directors, and employees. The Retention Plan allows for several different types of awards to be granted, including but not limited to, restricted share units and restricted share awards, collectively referred to as “share awards”. Share awards generally have the same expense characteristics under US GAAP and generally vest over a four-year period at a rate of 25% per annum.
Under the Retention Plan, the Company is authorized to issue shares of common stock to employees and non-employees up to ten percent (10%) of the total number of shares of common stock outstanding as of December 31, 2022, on a fully diluted basis. The Company adjusts the authorized shares under the plan each December 31, while the Retention Plan remains in effect. During the nine months ended March 31, 2024 and 2023, the Company granted 1.8 million and 2.6 million share awards, respectively.
14. Equity Compensation Awards (continued)
The table below reflects the share award activity for the period ended March 31, 2024:
| Units | Weighted- Average Grant Date Fair Value per Unit | |
|---|---|---|
| Unvested share awards at June 30, 2023 | 1,736,376 | $8.35 |
| Granted | 2,634,678 | 4.03 |
| Vested | (1,092,155) | 5.54 |
| Other | – | – |
| Forfeitures | – | $– |
| Unvested awards at March 31, 2024 | 3,278,899 | $5.71 |
As awards are granted, stock-based compensation equivalent to the fair market value on the date of grant is expensed over the requisite service period, using the graded vesting attribution method as acceptable under ASC 718, “Stock-Based Compensation.”
The Company recognized stock-based compensation expense of $12.3 million and $6.1 million for the nine months ended March 31, 2024 and 2023, respectively. Of these amounts, $5.0 million and $2.7 million, respectively, were related to officers and directors of the Company. For the nine months ended March 31, 2024 and 2023, total stock-based compensation expense included $1.3 million andnil related to warrants awarded to officers of the Company. As of March 31, 2024 and June 30, 2023, the equity compensation liability totaled $2.1 million and $0.8 million related to warrants awarded to officers of the Company. SeeCorrection of Previously Issued Consolidated Financial Statements in Note 2. As of March 31, 2023 several grant performance targets for the fiscal year ended June 30, 2024 have been defined via employee and retention agreements. These performance targets have not yet been achieved by employees and officers thus, the Company has deferred any stock-based compensation recognition until such achievements are probable of achievement and approval by the board of directors has occurred.
As of March 31, 2024 and June 30, 2023, there were approximately $10.3 million and $8.7 million of unamortized expenses relating to outstanding share awards to be recognized over a remaining weighted-average period of 3.0 years and 3.2 years, respectively.
The table below presents the stock-based compensation expense per respective line item on the consolidated statements of operations for the nine months ended March 31:
| 2024 | 2023 | |
|---|---|---|
| General and administrative | $6,143,765 | $3,588,076 |
| Research and development | 5,197,699 | 1,985,491 |
| Exploration | 952,592 | 505,322 |
| Stock-based compensation expense | $12,294,056 | $6,078,889 |
Executive officers and selected other key employees are eligible to receive common share performance-based awards, as determined by the board of directors. The payouts, in the form of share awards, vary based on the degree to which corporate operating objectives are met. These performance-based awards typically include a service-based requirement, which is generally four-years.
15. Supplemental Statement of Cash Flow Disclosures
For the nine months ended March 31:
| 2024 · 2023 | |||
|---|---|---|---|
| Supplemental disclosures: | |||
| Interest paid | $16,017 | $ | - |
| Non-cash investing and financing activities: | |||
| Current liabilities associated with investing activities | 1,999,331 | 1,938,564 | |
| Deposits capitalized as investing activities | 27,103,351 | 150,000 | |
16. Commitments and Contingencies
From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Except as otherwise identified herein, management is currently not aware of any such legal proceedings or claims that could have, individually or in aggregate, a material adverse effect on our business, financial condition, or operating results.
Operating Leases
The Company leases its principal office location in Reno, Nevada. It also leases lab space at the University of Nevada, Reno on short term leases. The principal office location lease expires on November 30, 2024 and the Lab leases expire on November 30, 2024. Consistent with the guidance in ASC 842, The Company has recorded the principal office lease in its consolidated balance sheet as an operating lease. For further information on operating lease commitments, see Note 11 – Leases.
Financial Assurance:
Nevada and other states, as well as federal regulations governing mine operations on federal land, require financial assurance to be provided for the estimated costs of mine reclamation and closure, including groundwater quality protection programs. The Company has satisfied financial assurance requirements using a combination of cash bonds and surety bonds. The amount of financial assurance The Company is required to provide will vary with changes in laws, regulations, reclamation and closure requirements, and cost estimates. At March 31, 2024, The Company’s financial assurance obligations associated with U.S. mine closure and reclamation/restoration cost estimate totaled $59,646, for which the Company is legally required to satisfy its financial assurance obligations for its mining properties in Tonopah, Nevada. The Company was previously released of all of its liability in the Railroad Valley region of Nevada.
17. Subsequent Events
On April 3, 2024, the Company entered into an ATM Sales Agreement (the “Sales Agreement”) with Virtu Americas LLC (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time through the Sales Agent, shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $50,000,000, subject to the terms and conditions of the Sales Agreement. The Company has filed a prospectus supplement to its registration statement on Form S-3 (File No. 333-252492) offering the Shares.
On April 24, 2024, the Company announced the completion of the “Amended Resource Estimate and Initial Assessment with Project Economics for the Tonopah Flats Lithium Project, Esmeralda and Nye Counties, Nevada, USA” (“Amended IA”) and the publication of the S-K 1300 Technical Report Summary (“TRS”) disclosing mineral resources, including an initial economic assessment, for the Tonopah Flats Lithium Project. The TRS was completed by RESPEC Company LLC, a qualified person, in compliance with Item 1300 of Regulation S-K and with an effective date of April 5, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.